Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab OzogamicinMichele Gottardi, Giovanni Martinelli, Giorgia Simonetti et al.|Cancers|2021Cited by 19
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trialsMassimo Gentile, Pellegrino Musto, Silvia Mangiacavalli et al.|Haematologica|2023Cited by 19
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow‐up of a multicenter, retrospective real‐world experience with 321 cases outside of controlled clinical trialsEnrica Antonia Martino, Pellegrino Musto, Salvatore Palmieri et al.|Hematological Oncology|2024Cited by 7
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical TrialClaudio Cerchione, Vincenzo Martinelli, Giovanni Martinelli et al.|Journal of Clinical Medicine|2020Cited by 6
Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple MyelomaClaudio Cerchione, Giovanni Martinelli, Lucio Catalano et al.|Blood|2020Cited by 0